Literature DB >> 9052913

Mycobacterial infections following bone marrow transplantation: a 20 year retrospective review.

V Roy1, D Weisdorf.   

Abstract

Mycobacterial infections are common in people with impaired cell-mediated immunity. Bone marrow transplant recipients have this defect and might be expected to have a high incidence of mycobacterial infections. We reviewed mycobacterial infections in 2241 BMT recipients at the University of Minnesota Hospital. Mycobacterial infections were diagnosed in 11 (0.49%), including nine of 1486 allograft recipients (0.6%) and two of 755 (0.26%) autograft recipients. Two patients had M. tuberculosis infection, two, M. avium-intracellulare infection and seven, infection with rapid growing atypical mycobacteria (M. fortuitum or M. chelonae). The manifestations included unexplained fever, pulmonary infiltrates, osteomyelitis or central venous catheter tunnel inflammation. Six of the seven infections with rapid growing atypical mycobacteria were related to central venous catheters. Appropriate local measures and therapy with antimycobacterial medications resulted in complete resolution of infection in the nine patients treated. The low incidence of mycobacterial infection observed in BMT recipients contrasts with that observed in people with impaired cell-mediated immunity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9052913     DOI: 10.1038/sj.bmt.1700686

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  21 in total

Review 1.  Mycobacterium szulgai: an unusual cause of disseminated mycobacterial infections.

Authors:  S Riedel; K Dionne; C Ellis; A Duffield; K C Carroll; N M Parrish
Journal:  Infection       Date:  2011-10-29       Impact factor: 3.553

2.  Bacteremia caused by the novel species Mycobacterium canariasense.

Authors:  M I Campos-Herrero; D García; A Figuerola; P Suárez; C Campo; M J García
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-01       Impact factor: 3.267

3.  A unique case of tuberculosis dissemination presenting as cutaneous lesions in a post allogeneic stem cell transplant patient.

Authors:  W Lam; A Viswabandya; S Hussain; H A Messner; F V Michelis; D D Kim; J H Lipton; U Deotare
Journal:  Bone Marrow Transplant       Date:  2016-05-16       Impact factor: 5.483

Review 4.  Mycobacterium lentiflavum, a recently identified slow-growing mycobacterial species: clinical significance in immunosuppressed cancer patients and summary of reported cases of infection.

Authors:  A Safdar; X Y Han
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-08       Impact factor: 3.267

5.  Update on nontuberculous mycobacterial infections in solid organ and hematopoietic stem cell transplant recipients.

Authors:  B M Knoll
Journal:  Curr Infect Dis Rep       Date:  2014-09       Impact factor: 3.725

6.  Analysis of Clinical Profile and Outcome of Tuberculosis in Patients with Acute Leukemia.

Authors:  Arihant Jain; Gaurav Prakash; Charanpreet Singh; Deepesh Lad; Alka Khadwal; Vikas Suri; Pankaj Malhotra; Savita Kumari; Neelam Varma; Subhash Varma
Journal:  Indian J Hematol Blood Transfus       Date:  2017-09-12       Impact factor: 0.900

7.  Catheter-related bloodstream infection caused by Mycobacterium brumae.

Authors:  Stephanie A Lee; Issam I Raad; Javier A Adachi; Xiang Y Han
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

Review 8.  Infections Caused by Rapidly Growing Mycobacteria spp in Children and Adolescents With Cancer.

Authors:  Nopporn Apiwattankul; Patricia M Flynn; Randall T Hayden; Elisabeth E Adderson
Journal:  J Pediatric Infect Dis Soc       Date:  2014-05-07       Impact factor: 3.164

9.  Multi-organ failure due to Mycobacterium tuberculosis and Aspergillus flavus infection after allogeneic bone marrow transplantation.

Authors:  Tuphan Kanti Dolai; R Kumar; R Bhargava; M Mahapatra; P Mishra; T Seth; R Kar; S Rathi; H P Pati; R Saxena; S Tyagi
Journal:  Indian J Hematol Blood Transfus       Date:  2008-08-24       Impact factor: 0.900

Review 10.  [Nontuberculous mycobacterial infections].

Authors:  A Nowag; M Platten; G Plum; P Hartmann
Journal:  Z Rheumatol       Date:  2017-11       Impact factor: 1.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.